Search - tctmd.com

Displaying 921 - 940 of 1439

Sort: Relevancy | Date

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Presentation TCT 2017

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Kiyohito Nakai

October 30, 2017

FDA Perspectives on HBD: Past, Present, and Future

Presentation TCT 2017

FDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Bram D. Zuckerman

October 30, 2017

TCTMD’s Top 10 Most Popular Stories for October 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

October 29, 2017

Transcatheter Mitral Valve Repair vs Medical Treatment for Severe Secondary MR

Presentation TCT 2017

Transcatheter Mitral Valve Repair vs Medical Treatment for Severe Secondary MR

Presenter: Jeroen J. Bax, Stephan Windecker, Alec S. Vahanian

October 29, 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

October 20, 2017

Why All Interventionalists Should Be on Twitter

News Opinion Fellow Talk

Why All Interventionalists Should Be on Twitter

Amit K. Gupta, MBBS, MD

October 18, 2017

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

October 16, 2017

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

News Daily News

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

October 13, 2017

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

News Daily News

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

October 04, 2017

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

News Daily News

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

September 22, 2017

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

News Daily News

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

September 19, 2017

News Industry News

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

September 19, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

September 08, 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

August 30, 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

August 27, 2017

Evolocumab Not Cost-Effective at Current List Price

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

Fellow Talk: Physical Fitness for Fellows: Better Late Than Never

News Opinion Fellow Talk

Physical Fitness for Fellows: Better Late Than Never

Bhuvnesh Aggarwal, MD

August 18, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.